Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
(NY:
MAIA
)
4.750
+0.360 (+8.20%)
Official Closing Price
Updated: 6:30 PM EDT, May 31, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
417,832
Open
4.450
Bid (Size)
4.750 (1)
Ask (Size)
4.900 (1)
Prev. Close
4.390
Today's Range
4.280 - 4.849
52wk Range
0.8200 - 4.000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
MAIA Biotechnology Inc (MAIA) Stock Surges as Company Prepares to Present Promising Data at BIO International Convention
Today 5:02 EDT
Via
AB Newswire
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
May 22, 2024
MAIA Biotechnology's Unique Telomere Targeting Agent Currently In Clinical Development Shows Promise For The Multi-Billion Dollar Cancer Therapy Market
Via
News Direct
Performance
YTD
+299.16%
+299.16%
1 Month
+76.58%
+76.58%
3 Month
+244.20%
+244.20%
6 Month
+305.98%
+305.98%
1 Year
+109.25%
+109.25%
More News
Read More
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation
May 21, 2024
Via
AB Newswire
MAIA Biotechnology to Present at the BIO International Convention 2024
May 17, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
May 16, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024
May 15, 2024
Via
InvestorPlace
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
April 30, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
April 29, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $1.00 Million Private Placement
April 23, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Present at Two Investor Conferences in April 2024
April 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
March 28, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
March 26, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces $1.33 Million Private Placement
March 26, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
March 22, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q4 2023
March 21, 2024
Via
InvestorPlace
MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
March 21, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
March 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
March 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology Announces Strong Efficacy of THIO as Third-Line Treatment for Non-Small Cell Lung Cancer Patients
March 06, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotechnology CEO Details Immuno-Oncology Cancer Treatment Candidates and Development Pipeline in Letter to Shareholders
March 05, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
MAIA Biotech Completes Enrollment For Phase 2 Trial Of Its Candidate THIO To Fight Non-Small Cell Lung Cancer
February 29, 2024
Via
News Direct
MAIA Biotechnology: Undervalued With Eye-Popping Cancer Data And Partnership Potential
February 22, 2024
Via
Talk Markets
MAIA Biotechnology Announces Publication in Nature Communications on Positive Effects of THIO for Potential Treatment of Small Cell Lung Cancer
February 07, 2024
From
MAIA Biotechnology, Inc.
Via
Business Wire
Novel Therapy Shows Promising Results In On-Going Trials, Receives 3 Orphan Drug Designations From The FDA
February 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 31, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.